Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118


Body composition and arsenic metabolism: a cross-sectional analysis in the Strong Heart Study.

Gribble MO, Crainiceanu CM, Howard BV, Umans JG, Francesconi KA, Goessler W, Zhang Y, Silbergeld EK, Guallar E, Navas-Acien A.

Environ Health. 2013 Dec 9;12:107. doi: 10.1186/1476-069X-12-107.


Urine arsenic concentrations and species excretion patterns in American Indian communities over a 10-year period: the Strong Heart Study.

Navas-Acien A, Umans JG, Howard BV, Goessler W, Francesconi KA, Crainiceanu CM, Silbergeld EK, Guallar E.

Environ Health Perspect. 2009 Sep;117(9):1428-33. doi: 10.1289/ehp.0800509. Epub 2009 May 7.


SLCO1B1 variants and urine arsenic metabolites in the Strong Heart Family Study.

Gribble MO, Voruganti VS, Cropp CD, Francesconi KA, Goessler W, Umans JG, Silbergeld EK, Laston SL, Haack K, Kao WH, Fallin MD, Maccluer JW, Cole SA, Navas-Acien A.

Toxicol Sci. 2013 Nov;136(1):19-25. doi: 10.1093/toxsci/kft181. Epub 2013 Aug 22.


The association of urine arsenic with prevalent and incident chronic kidney disease: evidence from the Strong Heart Study.

Zheng LY, Umans JG, Yeh F, Francesconi KA, Goessler W, Silbergeld EK, Bandeen-Roche K, Guallar E, Howard BV, Weaver VM, Navas-Acien A.

Epidemiology. 2015 Jul;26(4):601-12. doi: 10.1097/EDE.0000000000000313.


Arsenic exposure, arsenic metabolism, and incident diabetes in the strong heart study.

Kuo CC, Howard BV, Umans JG, Gribble MO, Best LG, Francesconi KA, Goessler W, Lee E, Guallar E, Navas-Acien A.

Diabetes Care. 2015 Apr;38(4):620-7. doi: 10.2337/dc14-1641. Epub 2015 Jan 12.


Evaluation of urinary speciated arsenic in NHANES: issues in interpretation in the context of potential inorganic arsenic exposure.

Aylward LL, Ramasamy S, Hays SM, Schoeny R, Kirman CR.

Regul Toxicol Pharmacol. 2014 Jun;69(1):49-54. doi: 10.1016/j.yrtph.2014.02.011. Epub 2014 Feb 25.


Creatinine, diet, micronutrients, and arsenic methylation in West Bengal, India.

Basu A, Mitra S, Chung J, Guha Mazumder DN, Ghosh N, Kalman D, von Ehrenstein OS, Steinmaus C, Liaw J, Smith AH.

Environ Health Perspect. 2011 Sep;119(9):1308-13. doi: 10.1289/ehp.1003393. Epub 2011 Jun 7.


Association between exposure to low to moderate arsenic levels and incident cardiovascular disease. A prospective cohort study.

Moon KA, Guallar E, Umans JG, Devereux RB, Best LG, Francesconi KA, Goessler W, Pollak J, Silbergeld EK, Howard BV, Navas-Acien A.

Ann Intern Med. 2013 Nov 19;159(10):649-59.


A prospective study of arsenic exposure, arsenic methylation capacity, and risk of cardiovascular disease in Bangladesh.

Chen Y, Wu F, Liu M, Parvez F, Slavkovich V, Eunus M, Ahmed A, Argos M, Islam T, Rakibuz-Zaman M, Hasan R, Sarwar G, Levy D, Graziano J, Ahsan H.

Environ Health Perspect. 2013 Jul;121(7):832-8. doi: 10.1289/ehp.1205797. Epub 2013 May 10.


Effects of obesity and body fat distribution on lipids and lipoproteins in nondiabetic American Indians: The Strong Heart Study.

Hu D, Hannah J, Gray RS, Jablonski KA, Henderson JA, Robbins DC, Lee ET, Welty TK, Howard BV.

Obes Res. 2000 Sep;8(6):411-21.


Urine arsenic and prevalent albuminuria: evidence from a population-based study.

Zheng LY, Umans JG, Tellez-Plaza M, Yeh F, Francesconi KA, Goessler W, Silbergeld EK, Guallar E, Howard BV, Weaver VM, Navas-Acien A.

Am J Kidney Dis. 2013 Mar;61(3):385-94. doi: 10.1053/j.ajkd.2012.09.011. Epub 2012 Nov 9.


Arsenic speciation analysis of urine samples from individuals living in an arsenic-contaminated area in Bangladesh.

Hata A, Yamanaka K, Habib MA, Endo Y, Fujitani N, Endo G.

Environ Health Prev Med. 2012 May;17(3):235-45. doi: 10.1007/s12199-011-0247-5. Epub 2011 Nov 3.


Seafood intake and urine concentrations of total arsenic, dimethylarsinate and arsenobetaine in the US population.

Navas-Acien A, Francesconi KA, Silbergeld EK, Guallar E.

Environ Res. 2011 Jan;111(1):110-8. doi: 10.1016/j.envres.2010.10.009. Epub 2010 Nov 19.


Arsenic exposure, diabetes prevalence, and diabetes control in the Strong Heart Study.

Gribble MO, Howard BV, Umans JG, Shara NM, Francesconi KA, Goessler W, Crainiceanu CM, Silbergeld EK, Guallar E, Navas-Acien A.

Am J Epidemiol. 2012 Nov 15;176(10):865-74. doi: 10.1093/aje/kws153. Epub 2012 Oct 24.


Urinary arsenic concentrations and speciation in residents living in an area with naturally contaminated soils.

Fillol C, Dor F, Labat L, Boltz P, Le Bouard J, Mantey K, Mannschott C, Puskarczyk E, Viller F, Momas I, Seta N.

Sci Total Environ. 2010 Feb 1;408(5):1190-4. doi: 10.1016/j.scitotenv.2009.11.046. Epub 2009 Dec 8.


Differences of urinary arsenic metabolites and methylation capacity between individuals with and without skin lesions in Inner Mongolia, Northern China.

Zhang Q, Li Y, Liu J, Wang D, Zheng Q, Sun G.

Int J Environ Res Public Health. 2014 Jul 18;11(7):7319-32. doi: 10.3390/ijerph110707319.


Associations between arsenic species in exfoliated urothelial cells and prevalence of diabetes among residents of Chihuahua, Mexico.

Currier JM, Ishida MC, González-Horta C, Sánchez-Ramírez B, Ballinas-Casarrubias L, Gutiérrez-Torres DS, Cerón RH, Morales DV, Terrazas FA, Del Razo LM, García-Vargas GG, Saunders RJ, Drobná Z, Fry RC, Matoušek T, Buse JB, Mendez MA, Loomis D, Stýblo M.

Environ Health Perspect. 2014 Oct;122(10):1088-94. doi: 10.1289/ehp.1307756. Epub 2014 Jun 27.


Variability in biomarkers of arsenic exposure and metabolism in adults over time.

Kile ML, Hoffman E, Hsueh YM, Afroz S, Quamruzzaman Q, Rahman M, Mahiuddin G, Ryan L, Christiani DC.

Environ Health Perspect. 2009 Mar;117(3):455-60. doi: 10.1289/ehp.11251. Epub 2008 Nov 19.


Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasis-hyperendemic area in Taiwan.

Hsueh YM, Huang YL, Huang CC, Wu WL, Chen HM, Yang MH, Lue LC, Chen CJ.

J Toxicol Environ Health A. 1998 Jul 24;54(6):431-44.

Items per page

Supplemental Content

Write to the Help Desk